SCHEMBL212630

SCHEMBL212630

C1CC2CCC1CNC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2388239 1.00
Hydrochloric Acid SCHEMBL7452837 0.96 CCR5 (0.40)
SCHEMBL8657415 0.91 CCR5 (0.43)
SCHEMBL8327948 0.89 CCR5 (0.35)
SCHEMBL25891553 0.89 CCR5 (0.35)
SCHEMBL27316 0.84
SCHEMBL13878152 0.84 CCR5 (0.38)
SCHEMBL15193376 0.84
Hydrochloric Acid SCHEMBL2186118 0.81
SCHEMBL7249921 0.81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 863 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130296237-A1 Use Of Chloroquine To Treat Metabolic Syndrome UNIV WASHINGTON (US) 2013-11-07 US claimed
US-8440695-B2 Use of chloroquine to treat metabolic syndrome ST JUDE CHILDREN'S RESEARCH HOSPITAL (US) 2013-05-14 US claimed
US-20050282872-A1 Novel thyroid receptor ligands and method II HANGELAND JON 2005-12-22 US claimed
EP-1453789-A2 N,N'-SUBSTITUTED-1,3-DIAMINO-2-HYDROXYPROPANE DERIVATIVES Elan Pharmaceuticals, Inc. (US) 2004-09-08 EP claimed
US-20040171881-A1 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives PHARMACIA & UPJOHN COMPANY 2004-09-02 US claimed
WO-2003040096-A2 N, N'-SUBSTITUTED-1,3-DIAMINO-2-HYDROXYPROPANE DERIVATIVES ELAN PHARMACEUTICALS, INC. (US) 2003-05-15 WO claimed
WO-2001092232-A1 4-AMINOQUINOLINES AS ANTIINFECTIVE AGENTS UFC LTD. (GB) 2001-12-06 WO claimed
EP-0684240-B1 Hydroxamic acid derivatives with three ring substituents HOFFMANN LA ROCHE (CH) 2000-08-02 EP claimed
EP-0609010-B1 A process for producing a diolefin polymer or copolymer and a rubber composition containing such a diolefin polymer or copolymer BRIDGESTONE CORP (JP) 2000-03-15 EP claimed
EP-0656353-B1 Aminochinoline derivates useful in the treatment of malaria HOFFMANN LA ROCHE (CH) 1998-06-03 EP claimed
US-4522943-A ANTISECRETORY ANTIULCER AGENT BRISTOL-MYERS COMPANY (US) 1985-06-11 US claimed
US-4503051-A ANTIULCER, HISTAMINE H2-ANTAGONIST BRISTOL-MYERS COMPANY (US) 1985-03-05 US claimed
EP-0099122-A2 Compositions comprising pepstatin and an histamine H2-receptor antagonist having an enhanced antiulcer activity Bristol-Myers Company (US) 1984-01-25 EP claimed
US-4385055-A 2-Acetyl-and 2-propionylpyridine thiosemicarbazones as antimalarials THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) 1983-05-24 US claimed
EP-0005586-B1 2,4,6-TRIS-(SUBSTITUTED-AMINO)-S-TRIAZINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AMERICAN CYANAMID COMPANY (US) 1982-04-28 EP claimed
US-4261892-A ANTIINFLAMMATORY, ANTIARTHRITIC AMERICAN CYANAMID COMPANY (US) 1981-04-14 US claimed
EP-0005586-A1 2,4,6-Tris-(substituted-amino)-S-triazines, process for their preparation and pharmaceutical compositions containing them AMERICAN CYANAMID COMPANY (US) 1979-11-28 EP claimed
US-4104380-A Dibenzyl glycolic acid derivatives WARNER-LAMBERT COMPANY (US) 1978-08-01 US claimed
US-4022834-A Antibacterially active hexamethylene-bis-biguanides A/S FARMACEUTISK INDUSTRI (NO) 1977-05-10 US claimed
US-4013638-A VULCANIZATION ACCELERATORS, OXIDATION INHIBITORS OF RUBBER MONSANTO COMPANY (US) 1977-03-22 US claimed